Healthcare -
Biotechnology - NASDAQ - US
$ 54.0
-1.66 %
$ 3.37 B
Market Cap
-12.44
P/E
Price Target
Average
19.58%
Revenue Forecast
Estimate
132.71%
EBIT
Estimate
--1.92%
Net Income
Estimate
57.33%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Rhythm Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for RYTM of $64.6 , with forecasts ranging from
a
low of
$55 to a high of $80 .
RYTM Lowest Price Target
Wall Street Target
55 USD
1.85%
RYTM Average Price Target
Wall Street Target
64.6 USD
19.58%
RYTM Highest Price Target
Wall Street Target
80 USD
48.15%
REVENUE FORECAST
Revenue Forecast Chart RYTM
EBIT FORECAST
EBIT Forecast Chart RYTM
NET INCOME FORECAST
Net Income Chart RYTM